Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Achilles Therapeutics Plc - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Achilles Therapeutics Plc - ADR market cap is $60.83M.
What is the 52-week high for Achilles Therapeutics Plc - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Achilles Therapeutics Plc - ADR 52 week high is $1.51 as of September 11, 2025.
What is the 52-week low for Achilles Therapeutics Plc - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Achilles Therapeutics Plc - ADR 52 week low is $0.63 as of September 11, 2025.
What is Achilles Therapeutics Plc - ADR stock price today?
Achilles Therapeutics Plc - ADR stock price today is $1.48.
What was Achilles Therapeutics Plc - ADR stock price yesterday?
Achilles Therapeutics Plc - ADR stock price yesterday was $1.47.
What is the PE ratio of Achilles Therapeutics Plc - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Achilles Therapeutics Plc - ADR’s P/E ratio is -0.89.
What is the Price-to-Book ratio of Achilles Therapeutics Plc - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Achilles Therapeutics Plc - ADR P/B ratio is 0.5898.
What is the 50-day moving average of Achilles Therapeutics Plc - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Achilles Therapeutics Plc - ADR 50-day moving average is $1.31.
